Synageva BioPharma (GEVA) Joins the International MPS Network in Support of MPS Awareness Day 2013
5/15/2013 10:00:18 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, joins the International MPS Network and others around the world in observing MPS Awareness Day 2013. During MPS Awareness day, patient organizations, industry, and other participants conduct special events to raise awareness of Mucopolysaccharidoses (MPS) disease. Today, Synageva employees will host a breakfast with family members of individuals affected by MPS IIIB, also known as Sanfilippo B syndrome, to discuss their various experiences and challenges when faced with this devastating disease.
Help employers find you! Check out all the jobs and post your resume.
comments powered by